Xilio Therapeutics, Inc. - XLO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Nov 16, 2026 SCHEDULE 13G ADAR1 Capital Management, LLC 9.3% 381,000 View
Nov 16, 2026 SCHEDULE 13G Daniel Schneeberger 9.3% 381,000 View
Nov 16, 2026 SCHEDULE 13G Logos Global Management LP 9.99% 730,315 View
Nov 16, 2026 SCHEDULE 13G Logos Global Management GP LLC 9.99% 730,315 View
Nov 16, 2026 SCHEDULE 13G Logos Opportunities Fund IV LP 9.99% 730,315 View
Nov 16, 2026 SCHEDULE 13G Logos Opportunities IV GP LLC 9.99% 730,315 View
Nov 16, 2026 SCHEDULE 13G Arsani William 9.99% 730,315 View
Nov 16, 2026 SCHEDULE 13G Graham Walmsley 9.99% 730,315 View
Nov 13, 2026 SCHEDULE 13G/A Coastlands Capital LP 9.99% 731,573 View
Nov 13, 2026 SCHEDULE 13G/A Coastlands Capital Partners LP 9.99% 731,573 View
Nov 13, 2026 SCHEDULE 13G/A Coastlands Capital GP LLC 9.99% 731,573 View
Nov 13, 2026 SCHEDULE 13G/A Coastlands Capital LLC 9.99% 731,573 View
Nov 13, 2026 SCHEDULE 13G/A Matthew D. Perry 9.99% 731,573 View
Nov 12, 2026 SCHEDULE 13G Adage Capital Management, L.P. 7.06% 464,598 View
Nov 12, 2026 SCHEDULE 13G Robert Atchinson 7.06% 464,598 View
Nov 12, 2026 SCHEDULE 13G Phillip Gross 7.06% 464,598 View
Aug 14, 2026 SCHEDULE 13G/A StemPoint Capital LP 9.5% 628,866 View
Aug 14, 2026 SCHEDULE 13G/A StemPoint Capital Management GP LLC 9.5% 628,866 View
Aug 14, 2026 SCHEDULE 13G/A Michelle Ross 9.5% 628,866 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.